20197-93-7

Basic information

• Product Name: [1,4]Dioxino[2,3-g]quinazoline-2,4(1H,3H)-dione, 7,8-dihydro-
• CAS NO: 20197-93-7
• Molecular Formula: C10H8N2O4
• Mol File: 20197-93-7.mol
• Article Data: 0

Chemical Properties

• CAS DataBase Reference: [1,4]Dioxino[2,3-g]quinazoline-2,4(1H,3H)-dione, 7,8-dihydro-(CAS DataBase Reference)
• NIST Chemistry Reference: [1,4]Dioxino[2,3-g]quinazoline-2,4(1H,3H)-dione, 7,8-dihydro-(20197-93-7)
• EPA Substance Registry System: [1,4]Dioxino[2,3-g]quinazoline-2,4(1H,3H)-dione, 7,8-dihydro-(20197-93-7)

Safety Data

• Hazardous Substances Data: 20197-93-7(Hazardous Substances Data)

Usage

Description

[1,4]Dioxino[2,3-g]quinazoline-2,4(1H,3H)-dione, 7,8-dihydrois a heterocyclic compound characterized by a quinazoline backbone and a dioxin ring fused to it. It is also referred to as quinazolinedione and is widely utilized in the synthesis of pharmaceutical compounds. [1,4]Dioxino[2,3-g]quinazoline-2,4(1H,3H)-dione, 7,8-dihydrohas demonstrated various biological activities, such as anticonvulsant and sedative effects, and is recognized for its potential medicinal applications. It serves as a valuable building block in the development of new drugs and remains a focal point of research within the pharmaceutical industry.

Uses

Used in Pharmaceutical Synthesis:
[1,4]Dioxino[2,3-g]quinazoline-2,4(1H,3H)-dione, 7,8-dihydrois used as a key intermediate in the synthesis of pharmaceutical compounds. Its unique structure and biological activities make it a promising candidate for the development of novel therapeutic agents.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, [1,4]Dioxino[2,3-g]quinazoline-2,4(1H,3H)-dione, 7,8-dihydrois employed as a building block for the design and synthesis of new drugs. Its versatile chemical properties and potential to exhibit various biological activities contribute to its significance in drug discovery and development.
Used in the Development of Anticonvulsant and Sedative Agents:
[1,4]Dioxino[2,3-g]quinazoline-2,4(1H,3H)-dione, 7,8-dihydrois used as a starting material for the development of anticonvulsant and sedative agents due to its demonstrated biological activities in these areas. Its potential to alleviate seizures and promote relaxation makes it a valuable asset in the search for new treatments for neurological disorders.
Used in Drug Design and Optimization:
[1,4]Dioxino[2,3-g]quinazoline-2,4(1H,3H)-dione, 7,8-dihydrois utilized in the drug design process to optimize the properties of new pharmaceutical compounds. Its structural features and biological activities can be leveraged to improve the efficacy, safety, and pharmacokinetic profiles of potential drug candidates.